Try our mobile app

Published: 2022-06-23 15:39:01 ET
<<<  go to FRBK company page
frbk20220623_8k.htm
false 0000834285 0000834285 2022-06-21 2022-06-21
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
June 21, 2022
Date of Report (Date of earliest event reported)
 
REPUBLIC FIRST BANCORP, INC.
(Exact name of registrant as specified in its charter)
 
Pennsylvania
 
000-17007
 
23-2486815
(State or other jurisdiction
 
(Commission
 
(IRS Employer
of incorporation)
 
File Number)
 
Identification No.)
 
50 South 16th Street, Suite 2400, Philadelphia, Pennsylvania
 
19102
(Address of principal executive offices)
 
(Zip Code)
 
(215) 735-4422
Registrant’s telephone number, including area code
 
N/A
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock FRBK Nasdaq Global Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
1

 
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
 
On June 21, 2022, Republic First Bancorp, Inc. (the “Company”) received notice from The NASDAQ Stock Market (“Nasdaq”) that, as a result of the death of Theodore J. Flocco, Jr., an independent director and member of the Company’s Audit Committee, the Company does not comply with the continued listing requirements under Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq-listed companies to have a minimum of three members and be comprised solely of independent directors.
 
Consistent with Nasdaq Listing Rule 5605(c)(4), the Nasdaq notice provides that Nasdaq will provide the Company a cure period in order to regain compliance as follows (the “Cure Period”): until the earlier of the Company’s next annual shareholders’ meeting or May 11, 2023; or if the next annual shareholders’ meeting is held before November 7, 2022, then the Company must evidence compliance no later than November 7, 2022. The Company is engaged in efforts to regain compliance with the majority independent board requirement set forth in Nasdaq Listing Rule 5605 and plans to regain compliance within the Cure Period provided by Nasdaq. The Company does not intend to update this Form 8-K for the purposes of disclosing any action or response that the Company decides to take after the date of filing of this Form 8-K under this Item 3.01.
 
Item 9.01
Financial Statements and Exhibits
 
(d) Exhibits
 
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
REPUBLIC FIRST BANCORP, INC.
 
       
Dated: June 23, 2022
     
       
 
By:
/s/ Frank A. Cavallaro
 
 
Name:
 
Frank A. Cavallaro
 
 
Title:
 
Executive Vice President and
Chief Financial Officer
 
 
2